Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.
about
Emerging Link between Alzheimer's Disease and Homeostatic Synaptic PlasticityImproving the predictive value of interventional animal models dataElevated emotional contagion in a mouse model of Alzheimer's disease is associated with increased synchronization in the insula and amygdalaAge-Dependent Modifications of AMPA Receptor Subunit Expression Levels and Related Cognitive Effects in 3xTg-AD Mice.Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.Gongjin-Dan Enhances Hippocampal Memory in a Mouse Model of Scopolamine-Induced Amnesia.Rodent models for Alzheimer's disease drug discovery.Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions.Development of an in-vivo active reversible butyrylcholinesterase inhibitor.ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice.A systems approach to drug discovery in Alzheimer's disease.The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind.A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25-35-impaired mouse cognitive function.Protective effects of testosterone on cognitive dysfunction in Alzheimer's disease model rats induced by oligomeric beta amyloid peptide 1-42.Unbiased classification of spatial strategies in the Barnes maze.Salidroside, a Bioactive Compound of Rhodiola Rosea, Ameliorates Memory and Emotional Behavior in Adult Mice.Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent.Effect of pregabalin on contextual memory deficits and inflammatory state-related protein expression in streptozotocin-induced diabetic mice.HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.Studies for Improving a Rat Model of Alzheimer's Disease: Icv Administration of Well-Characterized β-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory.Effect of pregabalin on fear-based conditioned avoidance learning and spatial learning in a mouse model of scopolamine-induced amnesia.Curcumin Reverses the Diazepam-Induced Cognitive Impairment by Modulation of Oxidative Stress and ERK 1/2/NF-κB Pathway in Brain.Rigor and Reproducibility in Rodent Behavioral Research.Brain 5-lipoxygenase over-expression worsens memory, synaptic integrity, and tau pathology in the P301S mice.Foxp1 in Forebrain Pyramidal Neurons Controls Gene Expression Required for Spatial Learning and Synaptic Plasticity.Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.A guide to using functional magnetic resonance imaging to study Alzheimer's disease in animal models.EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment.Highly sensitive/selective 3D nanostructured immunoparticle-based interface on a multichannel sensor array for detecting amyloid-beta in Alzheimer's disease
P2860
Q26750576-4C2F8FC6-81FD-4F4F-9917-1528EB9CC60BQ27026822-62498C9A-9229-4DFD-B4B6-DF4D8E3C3F68Q30844521-B9D0A2A7-7215-47DE-BE85-260EF4A11F1FQ34003920-F4F0978E-974A-4EE2-92E7-A259390E09C0Q36078803-31B68108-1DDE-45F6-9A22-99EE9E6E44FEQ36092576-021A1850-817C-4C10-99F7-70F6D6666FA1Q36117249-71970810-E394-4977-81DB-44EAD073E520Q36614145-3A2D65D2-A46F-416C-A1BD-E5FCBE8D0ECDQ37522451-1C3C4D5C-0A96-4DFD-84BE-EBD40A74A68FQ37635631-4C608E60-021B-44FA-B61A-94FF153F372EQ38327311-BDB96CCE-7046-4105-8032-FBB761674344Q38769710-5AB6C220-3E70-40ED-B248-A40FE2A0D6E7Q38820531-54086254-059E-4361-8DF2-C0BD647BE7BDQ39418837-1F676E4B-FD0B-4B6E-8CD0-3EC5CE1AAFF8Q39632045-F6F57FE5-A563-406B-9F2F-35425300B23EQ39929101-41ED9235-8F3F-409F-AA68-A95459771F4DQ40410650-95FC5B5E-8BB2-40D8-8EA6-5765535E02CFQ41138294-187D7EED-DD1D-4705-9F18-46497640C375Q41568885-10DCF7D3-C2EB-4AEE-9A8F-31671892AB60Q41628820-3E06F0E3-37FB-464C-B356-505BA32B7FBBQ46257963-474D75F6-DF6F-4F5F-8BDD-1DAA5B221723Q46442913-50066C96-CB07-4E96-ADF6-044EB5707225Q47110355-E806C835-484B-4C81-ADF1-652D6EB456FFQ47200848-A0F14984-C776-4CD4-BCE9-E53C6D2B9E06Q47438369-B4E3E370-3ECE-475B-B82C-6F6A6C12BFB3Q47619822-A0859AA3-B66B-4F42-93D2-034120657A36Q48488584-B0A23696-C2E7-4388-A778-D59CC6E281A1Q50533712-609AF3FD-4CB9-4D2E-84A9-3085542EAFF4Q54959405-1433643F-AA94-4176-B585-37569D0D1882Q55255033-20FE5AAF-D4B1-4668-940D-98436D118BBAQ57214783-AC19F7F3-1309-4DBB-A447-2B7B9479A63A
P2860
Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Behavioral assays with mouse m ...... considerations and guidelines
@nl
Behavioral assays with mouse m ...... considerations and guidelines.
@ast
Behavioral assays with mouse m ...... considerations and guidelines.
@en
type
label
Behavioral assays with mouse m ...... considerations and guidelines
@nl
Behavioral assays with mouse m ...... considerations and guidelines.
@ast
Behavioral assays with mouse m ...... considerations and guidelines.
@en
prefLabel
Behavioral assays with mouse m ...... considerations and guidelines
@nl
Behavioral assays with mouse m ...... considerations and guidelines.
@ast
Behavioral assays with mouse m ...... considerations and guidelines.
@en
P2860
P50
P3181
P1476
Behavioral assays with mouse m ...... considerations and guidelines.
@en
P2093
Giorgio Calabrese
P2860
P304
P3181
P356
10.1016/J.BCP.2014.01.011
P407
P577
2014-01-21T00:00:00Z